Found: 28
Select item for more details and to access through your institution.
The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 978, doi. 10.1111/bjh.17062
- By:
- Publication type:
- Article
The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. E119, doi. 10.1002/ajh.26886
- By:
- Publication type:
- Article
The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211047349
- By:
- Publication type:
- Article
The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211047349
- By:
- Publication type:
- Article
Clinical considerations about the coexistence of melanoma and chronic lymphocytic leukemia in the era of targeted therapies, triggered by rare clinical scenarios. A case series and review of the literature.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920962369
- By:
- Publication type:
- Article
Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 12, p. 2711, doi. 10.1007/s00277-022-05003-6
- By:
- Publication type:
- Article
Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Staphylococcus aureus meningitis in a patient with mantle cell lymphoma under treatment with ibrutinib.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 765, doi. 10.1007/s00262-019-02311-1
- By:
- Publication type:
- Article
Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 2046, doi. 10.3390/jcm13072046
- By:
- Publication type:
- Article
Post-Myelofibrosis Acute Myeloid Leukemia Effectively Treated with a Combination of Ruxolitinib and 5-Azacytidine.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 532, doi. 10.1159/000502121
- By:
- Publication type:
- Article
Prognostic Impact of Serum β 2 -Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 238, doi. 10.3390/cancers16020238
- By:
- Publication type:
- Article
COVID-19 in Patients with Melanoma: A Single-Institution Study.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 96, doi. 10.3390/cancers16010096
- By:
- Publication type:
- Article
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with Immunotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3791, doi. 10.3390/cancers14153791
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy in the context of newer therapies in hematology and review of new treatment strategies.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 5, p. 359, doi. 10.1111/ejh.13751
- By:
- Publication type:
- Article
Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemia.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 9, p. 2240, doi. 10.1002/cam4.804
- By:
- Publication type:
- Article
Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.722507
- By:
- Publication type:
- Article
Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literature.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231155991
- By:
- Publication type:
- Article
Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221090150
- By:
- Publication type:
- Article
Survivin Messenger RNA Levels in Epstein-Barr Viruse Positive Patients With Leukemic Low-Grade B-Cell Lymphomas Expressing the Latent Membrane Protein 1: Evidence of Apoptotic Function?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2014, v. 14, n. 1, p. 56, doi. 10.1016/j.clml.2013.09.002
- By:
- Publication type:
- Article
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cover Image.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. i, doi. 10.1002/hon.2866
- By:
- Publication type:
- Article
Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5‐azacytidine—data from the Hellenic myelodysplastic syndrome study group
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 231, doi. 10.1002/hon.2834
- By:
- Publication type:
- Article
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher‐risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 541, doi. 10.1002/hon.2756
- By:
- Publication type:
- Article
An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review.
- Published in:
- Advances in Hematology, 2024, v. 2024, p. 1, doi. 10.1155/2024/1370364
- By:
- Publication type:
- Article
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort study.
- Published in:
- EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.30
- By:
- Publication type:
- Article
PARP1-Driven Apoptosis in Chronic Lymphocytic Leukemia.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/106713
- By:
- Publication type:
- Article